Immune Boost In Non-Small Cell Lung Cancer

Exclusion Criteria

• •The patient shows clinical signs of pneumonia
• •The patient receives immunosuppressive drugs (alkylating agents, antimetabolites, methotrexate, azathioprine, mercaptopurine, cytotoxic antibodies, ciclosporin, tacrolimus, sirolimus, interferon, mycophenolate, small biological agents)
• •The patient has been diagnosed with a potential immune mediated disease
• •Elevated blood leukocyte count or erythrocyte sedimentation rate
• •Pregnancy
• •The patient has received any cancer specific treatment, including radiotherapy, immunotherapy, hormonal therapy or chemotherapy
• •The patient is diagnosed with a concomitant malignancy and/or has a history of malignancy within the past five years or has had a malignancy that has been in complete remission for less than 5 years
• •The patient needs chronic long term oxygen therapy
• •The patient has undergone splenectomy
• •The patient is known to be HIV positive
• •The patient has an uncontrolled bleeding disorder